1968
DOI: 10.1001/archinte.1968.03640010026004
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Evaluation of Cephaloridine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1969
1969
1976
1976

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 29 publications
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…4 Renal dysfunction may occur during treatment with cephaloridine and, less frequently, with cephalothin.5 Acute toxic effects of cephaloridine include necrosis of the proximal convoluted tubules in mice, rats, guinea pigs, rabbits, monkeys, and man. [5][6][7][8][9] Repeated administration in rats of 50 to 150 mg/kg/day of cephaloridine produces proteinuria,10 while moderate to large doses may produce massive cylindruria in humans.7,11…”
mentioning
confidence: 99%
“…4 Renal dysfunction may occur during treatment with cephaloridine and, less frequently, with cephalothin.5 Acute toxic effects of cephaloridine include necrosis of the proximal convoluted tubules in mice, rats, guinea pigs, rabbits, monkeys, and man. [5][6][7][8][9] Repeated administration in rats of 50 to 150 mg/kg/day of cephaloridine produces proteinuria,10 while moderate to large doses may produce massive cylindruria in humans.7,11…”
mentioning
confidence: 99%